Effect of Nicotine Gingival Fibroblast Intoxication on the Response of Periodontal Treatment (ENIPT's)

April 17, 2026 updated by: Leila Salhi, University of Liege

Effect of Nicotine Gingival Fibroblast Intoxication on the Response of Periodontal Treatment, in Conventional and Non Smokers: a Controlled Clinical Trial

Impact of nicotine gingival intoxication on the clinical outcomes after periodontitis non surgical treatment

Study Overview

Status

Enrolling by invitation

Detailed Description

In patients suffured of periodontitis, to evaluate the effect of nicotine gingival tissue intoxication and others smoking indicators on the severity of periodontitis and outcomes after nonsurgical periodontal treatment."

Study Type

Interventional

Enrollment (Estimated)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Liege
      • Liège, Liege, Belgium, 4000
        • Departement of periodontology, buccal surgery and implantology- Uliège, Belgium

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: patient suffured of periodontitis, smoker and non-smoker

  • patient suffured of periodontitis
  • smoker and non-smoker
  • presence of a minimum of 6 teeth at each arch
  • minimum of 6 teeth with pocket depth of 5 mm
  • signed informed consent

Exclusion Criteria:

  • diabetes,
  • connective tissue disease
  • pregnancy
  • radiotherapy
  • chemotherapy
  • psychological disease
  • previous periodontal therapy
  • antibiotics intake

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: conventionnal smoker group
patient who smokes conventionnal cigarette

The procedure will consist of non-surgical periodontal treatment (NSPT), consisting of the removal of supra- and subgingival plaque using ultrasonic instruments.

Prior to the NSPT, all unstimulated saliva will be collected using Eppendorf.

During local anesthesia for the NSPT, a gingival tissue biopsy will be performed using a 2mm wide and 4mm deep punch in the maxillary retromolar area behind the last tooth in the arch.

Placebo Comparator: Non smoker group
patient who don't smoke cigarette

The procedure will consist of non-surgical periodontal treatment (NSPT), consisting of the removal of supra- and subgingival plaque using ultrasonic instruments.

Prior to the NSPT, all unstimulated saliva will be collected using Eppendorf.

During local anesthesia for the NSPT, a gingival tissue biopsy will be performed using a 2mm wide and 4mm deep punch in the maxillary retromolar area behind the last tooth in the arch.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
nicotine/cotinine in gum (ng/ml)
Time Frame: the day of the periodontal non surgical treatment
concentration cotinine and nicotine (ng/ml)
the day of the periodontal non surgical treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PD (mm)
Time Frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
periodontal pocket depth (mm) Secondary outcomes: percentage of sites with PD ≥ 6 mm, furcation involvement, mobility assessment, bleeding on probing score (BoP), plaque score (PI).
baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
% PD ≥ 6 mm (%)
Time Frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
percentage of sites with PD ≥ 6 mm
baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
PY (number/year)
Time Frame: the day of periodontal non-surgical treatment
number of packet of cigarettes smoked per year
the day of periodontal non-surgical treatment
NCC (0 to 100)
Time Frame: the day of periodontal non-surgical treatment

number of cigartes consummed per day

  • PK: number of packet of cigarettes smoked per year
  • FTND: Fagerström test for nictnie dependance
the day of periodontal non-surgical treatment
Furc (I,II or III)
Time Frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
furcation involvement
baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
periodontal ouctomes
Time Frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
tooth mobility ( 1,2 or 3)
baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
BOP (%)
Time Frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
bleeding on probing
baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
PI (%)
Time Frame: baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
plaque score
baseline, the day of periodontal non- surgical treatment(PNST) , 3,6 and 12 months after PNSTs after
FTND score ( 0 to 9)
Time Frame: the day of periodontal non-surgical treatment
Fagerström test for nictnie dependance ( scale from 0 to 9) 0-2: Very low dependence 3-4: Low dependence 5: Medium dependence 6-7: High dependence 8-10: Very high dependence
the day of periodontal non-surgical treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2025

Primary Completion (Estimated)

June 1, 2029

Study Completion (Estimated)

June 1, 2029

Study Registration Dates

First Submitted

April 11, 2025

First Submitted That Met QC Criteria

March 18, 2026

First Posted (Actual)

March 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on periodontal non-surgical treatment

Subscribe